Capreomycin sulfate labels and packages: Difference between revisions

Revision as of 00:30, 25 December 2013

Capreomycin Sulfate
CAPASTAT SULFATE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

CAPASTAT® SULFATE Container Label Principal Display Panel Text:^[1]

1 VIAL NDC 17478-080-50

CAPASTAT® SULFATE

CAPREOMYCIN FOR INJECTION, USP

Equivalent to 1 g Capreomycin Activity

Rx only

CAPASTAT® SULFATE Carton Label Principal Display Panel Text:

CAPASTAT® SULFATE

CAPREOMYCIN FOR INJECTION, USP

Equivalent to 1 g Capreomycin Activity

FOR INTRAMUSCULAR AND INTRAVENOUS INFUSION ONLY

Rx only

Adapted from the FDA Package Insert.

Revision as of 00:30, 25 December 2013 (view source) Chetan Lokhande (talk \| contribs) No edit summary ← Older edit		Revision as of 00:30, 25 December 2013 (view source) Chetan Lokhande (talk \| contribs) No edit summary Newer edit →
Line 29:		Line 29:


	CAPASTAT® SULFATE Carton Label Principal Display Panel Text:		CAPASTAT® SULFATE Carton Label Principal Display Panel Text:

	CAPASTAT®		CAPASTAT®